3 Reasons Growth Investors Will Love Exelixis (EXEL)

Zacks Investment Research highlights Exelixis (EXEL) as a compelling growth stock, assigning it an 'A' Growth Score and a Zacks Rank #2 (Buy). This positive outlook is driven by the company's projected 32% EPS growth for the current year, significantly outperforming the industry average of 20.2%, and its robust year-over-year cash flow growth of 135.6% against an industry decline. Furthermore, positive current-year earnings estimate revisions, with a 2.9% surge in the Zacks Consensus Estimate over the past month, reinforce EXEL's position as a potential outperformer for growth-oriented investors.

Analysis

Exelixis (EXEL) is being highlighted as a strong growth candidate based on a proprietary model from Zacks Investment Research, which assigns the firm a 'Buy' rating and a top-tier 'A' Growth Score. The recommendation is supported by several key quantitative metrics that indicate fundamental outperformance. The company's projected EPS growth for the current year stands at 32%, significantly outpacing the industry average of 20.2%. Furthermore, EXEL demonstrates superior capital generation with a year-over-year cash flow growth of 135.6%, a stark contrast to the industry's average contraction of 4.5%. This strong current performance is built on a solid foundation, with its historical annualized cash flow growth of 10.8% over the past 3-5 years also exceeding the industry's 3.7%. Reinforcing the positive outlook, the stock has seen upward earnings estimate revisions, with the Zacks Consensus Estimate for the current year increasing by 2.9% in the last month, a trend often correlated with near-term price appreciation.

Key Decisions for Investors

• Given the strong quantitative signals for earnings and cash flow growth that significantly exceed industry benchmarks, growth-oriented investors should consider EXEL as a potential outperformer.
• The investment thesis is heavily dependent on forward-looking projections; therefore, it is critical to monitor upcoming earnings releases to validate that the projected 32% EPS growth and strong cash flow are materializing.
• Investors should pay close attention to the trend in analyst earnings estimates, as the reported 2.9% upward revision is cited as a key near-term catalyst, and any reversal of this trend could signal a change in momentum.